BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7885047)

  • 21. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 22. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
    Sandoval C; Jayabose S
    Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect.
    Chiu EK; Chan LC; Liang R; Lie A; Kwong YL; Todd D; Chan TK
    Leukemia; 1994 Sep; 8(9):1469-73. PubMed ID: 8090027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
    Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
    [No Abstract]   [Full Text] [Related]  

  • 27. Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.
    Torun YA; Patiroglu T; Ozdemir MA; Ozkul Y; Ekici A; Karakukcu M
    Clin Appl Thromb Hemost; 2012; 18(2):218-21. PubMed ID: 21873357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
    Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Bancillon A
    Arch Fr Pediatr; 1991 Oct; 48(8):593-4. PubMed ID: 1768205
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased factor VIII activity and dural sinus thrombosis.
    Celkan T; Ozkan A; Apak H; Kuruoglu S; Yuksel L; Yildiz I
    Med Pediatr Oncol; 2002 Jul; 39(1):71-2. PubMed ID: 12116089
    [No Abstract]   [Full Text] [Related]  

  • 33. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
    Li Y; Qiu L; Zou D; Zhao Y; Mi Y; Wang J
    Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Mandelli F; Annino L; Vegna ML; Camera A; Ciolli S; Deplano W; Fabiano F; Ferrara F; Ladogana S; Muti G
    Leukemia; 1992; 6 Suppl 2():182-5. PubMed ID: 1578928
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
    Shimamoto Y; Imai S; Endo N
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
    Ribera JM; Oriol A; Sanz MA; Tormo M; Fernández-Abellán P; del Potro E; Abella E; Bueno J; Parody R; Bastida P; Grande C; Heras I; Bethencourt C; Feliu E; Ortega JJ
    J Clin Oncol; 2008 Apr; 26(11):1843-9. PubMed ID: 18398150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M; Zelenay E
    Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prognostic value of the reaction to steroids in the treatment of acute lymphoblastic leukemia in children].
    Urasiński T; Peregud-Pogorzelski J; Bartoszewicz L
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):360-2. PubMed ID: 1437754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.